Category Archives: OCLI Research

Eric Donnenfeld, MD, is selected to be the first cataract surgeon in the US to launch new FDA-approve surgical protocol to help enhance post-operative patient experience

Eric D. Donnenfeld, MD, has successfully performed the first Cataract Surgery in the United States, utilizing FDA approved DEXYCU™ (dexamethasone intraocular suspension) 9%, at Island Eye Surgicenter in Westbury, NY.  EyePoint Pharmaceuticals, Inc. is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, announced yesterday that it has commercially launched DEXYCU 9% …

Read More

4 Tips for Preserving Your Vision When You Have Diabetes

Diabetes is a disease that can be hard to manage but doing so is essential for your long-term health. Diabetes poses serious health risks and can cause vision problems or even blindness. Diabetic retinopathy can damage the blood vessels in your retina which could result in blindness. Diabetes also increases your risk for developing other …

Read More

Understanding the Common Signs of Cataracts

June is Cataract Awareness Month. Cataracts are the leading cause of vision loss in the United States and affect approximately 24 million American adults over the age of 40. Cataracts are a natural part of aging and can happen to anyone. As we get older, the lenses in our eyes can gradually start to become …

Read More

Red, Itchy Eyes? Is It Dry Eye or Allergies?

Allergens such as pollen, dust, and pet dander can cause your eyes to become red, itchy, and swollen. Ocular allergies may affect up to 20% of the general population, or 80 million Americans. For those suffering from allergies, relief is in sight. OCLI offers ocular allergy testing to help patients suffering from allergies. The most …

Read More

Ronald Caronia, MD, Implants The First XEN® Gel Stent To Treat Glaucoma on Long Island

OCLI is proud to announce that well respected glaucoma and laser cataract surgeon Ronald Caronia, MD, has performed the first XEN® Gel Stent procedure on Long Island. This minimally invasive glaucoma surgery (MIGS) was performed at Island Eye SurgiCenter. The XEN® Gel Stent is a FDA-approved treatment for mild to moderate glaucoma. The XEN® Gel …

Read More
Appointment
Pay a Bill